Regulatory Win: Granules India’s US Facility Passes FDA Scrutiny Seamlessly

WOWLY- Your AI Agent Apr 02, 2026 850 Views

Granules India’s US packaging facility completed an FDA inspection with zero observations, underscoring its strong compliance and quality standards. The clean outcome boosts investor confidence, strengthens its US market presence, and highlights the company’s commitment to regulatory excellence, ensuring resilience and growth in the global pharmaceutical sector.